Suppr超能文献

金属蛋白酶组织抑制剂-1 mRNA核酶体外核酶的制备与表征

[Preparation and characterization of ribozyme for tissue inhibitor of metalloproteinases-1 mRNA ribozymes in vitro].

作者信息

Wang Zi-Min, Wu Jian-Ming, Lin Zi-Hao, Jiang Hua, Song Yu-Hu, Jin You-Xin

机构信息

State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences, Shanghai 200031, China.

出版信息

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Apr;35(4):387-90.

Abstract

To study the activity of the U6 driven ribozymes for tissue inhibitor of metalloproteinases-1(TIMP-1) mRNA and explore their use to cure hypertrophic scar, the ribozyme gene was designed according to the hammerhead structure described by Symons and then was cloned into pBSKneorU6, a vector containing mutant human U6 gene. TIMP-1 cDNA fragments were cloned into T-vector pGEM-T, to form the plasmid pTIMP-1. [(32)P]-labeled TIMP-1 transcripts as target RNAs and [(32)P]-labeled ribozyme, which was transcribed from the template that had been amplified from the corresponding cloning plasmids in vitro, were incubated together under various conditions for cleavage reactions. The reaction mixtures were electrophoresed on PAGE and autoradiographed. The results showed that the ribozyme(U6-Rz358) cleaved the mRNA successfully at 37 degrees; and the cleavage activity was best at 50 degrees ( K(m)=39.6 nmol/L, k(cat)=0.21 min(-1)), and the cleavage efficiencies were up to 76.34% at 50 degrees and 55.21% at 37 degrees. The designed ribozymes possessed perfect specific cleavage activity to TIMP-1. These findings suggested the potential application of this ribozyme as a new therapeutic agent against hypertrophic scar.

摘要

为研究U6驱动的金属蛋白酶组织抑制剂-1(TIMP-1)mRNA核酶的活性,并探索其在治疗增生性瘢痕中的应用,根据Symons描述的锤头结构设计核酶基因,然后将其克隆到含有突变型人U6基因的载体pBSKneorU6中。将TIMP-1 cDNA片段克隆到T载体pGEM-T中,构建质粒pTIMP-1。将[(32)P]标记的TIMP-1转录本作为靶RNA,与从相应克隆质粒体外扩增的模板转录的[(32)P]标记核酶在不同条件下共同孵育进行切割反应。反应混合物经聚丙烯酰胺凝胶电泳(PAGE)分离并放射自显影。结果显示,核酶(U6-Rz358)在37℃时能成功切割mRNA;在50℃时切割活性最佳(K(m)=39.6 nmol/L,k(cat)=0.21 min(-1)),50℃时切割效率达76.34%,37℃时为55.21%。所设计的核酶对TIMP-1具有良好的特异性切割活性。这些结果提示该核酶作为一种治疗增生性瘢痕的新型治疗剂具有潜在应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验